Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non–Small-Cell Lung Cancer: Results from a Large and Pooled Microarray Database-Reference-Cited by-同舟云学术

Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non–Small-Cell Lung Cancer: Results from a Large and Pooled Microarray Database

Published:2015-07 Issue:7 Volume:10 Page:1020-1026
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Deng Lei,Gyorffy Balazs,Na Feifei,Chen Baoqing,Lan Jie,Xue Jianxin,Zhou Lin,Lu You

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Immune checkpoint inhibitors in NSCLC;Johnson;Curr Treat Options Oncol,2014

2. Cancer immunotherapy comes of age;Mellman;Nature,2011

3. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

4. Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer;Zielinski;Ann Oncol,2013

5. Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes;Yang;Eur J Cancer,2014

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-cancer multi-omics analysis of PTBP1 reveals it as an inflammatory, progressive and prognostic marker in glioma;Scientific Reports;2024-06-25

2. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer;International Immunopharmacology;2022-12

3. Immunohistochemical expression of CD8, CTLA4, and PD-L1 in NSCLC of smokers versus non smokers and its effect on prognosis;Alexandria Journal of Medicine;2022-08-02

4. Expression Profile of Selected Antitumor Immune Response Genes in Pediatric Classic Hodgkin Lymphoma;Applied Immunohistochemistry & Molecular Morphology;2022-03-16

5. A Radiomic Model to Predict the Expression of Pd-1 and Overall Survival of Patients with Ovary Cancer;SSRN Electronic Journal;2022